Janssen Biotech, Inc. (20240291660). CENTRALIZED AND DECENTRALIZED INDIVIDUALIZED MEDICINE PLATFORM simplified abstract

CENTRALIZED AND DECENTRALIZED INDIVIDUALIZED MEDICINE PLATFORM

Organization Name

Janssen Biotech, Inc.

Inventor(s)

Khurram Mahmood of San Ramon CA (US)

Eric Matthew Bell of Emeryville CA (US)

Stuart Maxwell Altman of El Cerrito CA (US)

Jeremy Alan Dunn of Oakland CA (US)

Sambasiva R. Pedapalli of San Roman CA (US)

Christopher Prado Dunn of San Francisco CA (US)

Nerses Ohanyan of North Hollywood CA (US)

Anand Kothari of Cupertino CA (US)

Ryan Jeffrey Southwick of Pacifica CA (US)

Richard Brewster Wickersham, Iii of San Francisco CA (US)

CENTRALIZED AND DECENTRALIZED INDIVIDUALIZED MEDICINE PLATFORM - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240291660 titled 'CENTRALIZED AND DECENTRALIZED INDIVIDUALIZED MEDICINE PLATFORM

The subject disclosure pertains to systems, devices, and methods for executing operations related to the procurement of individualized medicine therapies. It also includes embodiments of systems, methods, and devices for accessing a wide range of individualized medicine platform modules. Furthermore, the disclosure involves individualized medicine platform systems, methods, and devices that are communicatively coupled to blockchain computing systems comprising several nodes. The disclosed systems, methods, and devices also generate chain of custody and chain of identity event data.

• Systems, devices, and methods for procuring individualized medicine therapies
• Accessing various individualized medicine platform modules
• Communication between individualized medicine platform systems and blockchain computing systems
• Generation of chain of custody and chain of identity event data

Potential Applications: This technology can be applied in the healthcare industry for personalized medicine treatments, pharmaceutical research, and supply chain management.

Problems Solved: This technology addresses the need for personalized medicine therapies, secure data management, and traceability in the healthcare supply chain.

Benefits: The benefits of this technology include improved patient outcomes, enhanced data security, and streamlined procurement processes for individualized medicine therapies.

Commercial Applications: Title: Innovative Individualized Medicine Procurement System This technology can be commercially used by pharmaceutical companies, healthcare providers, and research institutions to enhance personalized medicine treatments and optimize supply chain operations.

Prior Art: Readers can explore prior art related to blockchain technology in healthcare, personalized medicine platforms, and supply chain management systems.

Frequently Updated Research: Stay updated on the latest advancements in blockchain applications in healthcare, personalized medicine technologies, and data security protocols.

Questions about Individualized Medicine Procurement: 1. How does blockchain technology enhance the security of individualized medicine procurement processes? 2. What are the key challenges in implementing individualized medicine platforms with blockchain integration?

Original Abstract Submitted

the subject disclosure relates to systems, devices, and methods for executing operations related to procurement of individualized medicine therapies. also disclosed are embodiments systems, methods, and devices for accessing a wide range of individualized medicine platform modules. furthermore, disclosed herein are individualized medicine platform systems, methods and devices communicatively coupled to blockchain computing systems comprising several nodes. the disclosed systems, methods, and devices also generate chain of custody and chain of identity event data.